Association between serum 25-hydroxyvitamin D levels and carotid atherosclerosis in chronic kidney disease patients

BMC Nephrology

Volumn 17, Issue 1, 2016, Pages

  Ng, Yong Muh ^a   Lim, Soo Kun ^a   Kang, Pei San ^a   Kadir, Khairul Azmi Abdul ^a   Tai, Mei Ling Sharon ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Carotid atherosclerosis; Carotid intima media thickness; Carotid plaque; Chronic kidney disease; Parathyroid hormone; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; VITAMIN D;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD FLOW VELOCITY; CAROTID ARTERY; CAROTID ARTERY OBSTRUCTION; CAROTID ATHEROSCLEROSIS; CHEMILUMINESCENCE IMMUNOASSAY; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DIASTOLE; DISEASE ASSOCIATION; ECHOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIPLE LINEAR REGRESSION ANALYSIS; SYSTOLE; ULTRASOUND TRANSDUCER; VITAMIN D DEFICIENCY; AGED; ANALOGS AND DERIVATIVES; ATHEROSCLEROSIS; BLOOD; CAROTID ARTERY DISEASE; CHRONIC KIDNEY FAILURE; COMPLICATION; DIAGNOSTIC IMAGING;

AGED; ATHEROSCLEROSIS; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CAROTID STENOSIS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84992168469     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/s12882-016-0367-7     Document Type: Article

References (45)

1. Lusis AJ. Atherosclerosis. Nature. 2000;407(6801):233-41.
2. Carbone F, Montecucco F. The role of the intraplaque vitamin d system in atherogenesis. Scientifica. 2013;2013:620504.
3. Kassi E, Adamopoulos C, Basdra EK, Papavassiliou AG. Role of vitamin D in atherosclerosis. Circulation. 2013;128(23):2517-31.
4. Perez-Lopez FR. Vitamin D: the secosteroid hormone and human reproduction. Gynecol Endocrinol. 2007;23(1):13-24.
5. Menezes AR, Lamb MC, Lavie CJ, DiNicolantonio JJ. Vitamin D and atherosclerosis. Curr Opin Cardiol. 2014;29(6):571-7.
6. Holick MF. Vitamin D, deficiency. N Engl J Med. 2007;357:266-81.
7. Holick MF. Vitamin D, status: measurement, interpretation, and clinical application. Ann Epidemiol. 2009;19(2):73-8.
8. Kokubo Y. Carotid atherosclerosis in kidney disease. Contrib Nephrol. 2013;179:35-41.
9. Coll B, Betriu A, Martinez-Alonso M, Borras M, Craver L, Amoedo ML, et al. Cardiovascular risk factors underestimate atherosclerotic burden in chronic kidney disease: usefulness of non-invasive tests in cardiovascular assessment. Nephrol Dial Transplant. 2010;25(9):3017-25.
10. Nigwekar SU, Tamez H, Thadhani RI. Vitamin D and chronic kidney disease-mineral bone disease (CKD-MBD). BoneKEy Reports. 2014;3.
11. Williams S, Malatesta K, Norris K. Vitamin D and Chronic Kidney Disease. Ethn Dis. 2009;19(4 Suppl 5):S5-8-11.
12. Yadav AK, Banerjee D, Lal A, Jha V. Vitamin D deficiency, CD4 + CD28null cells and accelerated atherosclerosis in chronic kidney disease. Nephrol (Carlton, Vic). 2012;17(6):575-81.
13. Gracia M, Betriu A, Martinez-Alonso M, Arroyo D, Abajo M, Fernandez E, et al. Predictors of Subclinical Atheromatosis Progression over 2 Years in Patients with Different Stages of CKD. Clin J Am Soc Nephrol. 2016;11(2):287-96.
14. Carter GD. 25-Hydroxyvitamin D assays: the quest for accuracy. Clin Chem. 2009;55(7):1300-2.
15. Freeman J, Wilson K, Spears R, Shalhoub V, Sibley P. Influence of Vitamin D Binding Protein on Accuracy of 25-Hydroxyvitamin D Measurement Using the ADVIA Centaur Vitamin D Total Assay. Int J Endocrinol. 2014;2014:12.
16. Freeman J, Wilson K, Spears R, Shalhoub V, Sibley P. Performance evaluation of four 25-hydroxyvitamin D assays to measure 25-hydroxyvitamin D2. Clin Biochem. 2015;48(16-17):1097-104.
17. Lee JH, O'Keefe JH, Bell D, Hensrud DD, Holick MF. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol. 2008;52(24):1949-56.
18. Onut R, Balanescu APS, Constantinescu D, Calmac L, Marinescu M, Dorobantu PM. Imaging Atherosclerosis by Carotid Intima-media Thickness in vivo: How to, Where and in Whom? Maedica (Buchar). 2012;7(2):153-62.
19. Howard G, Sharrett AR, Heiss G, Evans GW, Chambless LE, Riley WA, et al. Carotid artery intimal-medial thickness distribution in general populations as evaluated by B-mode ultrasound. ARIC Investigators. Stroke. 1993;24(9):1297-304.
20. Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, et al. Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc Dis (Basel, Switzerland). 2007;23(1):75-80.
21. Grant EG, Benson CB, Moneta GL, Alexandrov AV, Baker JD, Bluth EI, et al. Carotid artery stenosis: gray-scale and Doppler US diagnosis - Society of Radiologists in Ultrasound Consensus Conference. Radiology. 2003;229(2):340-6.
22. Ford JA, MacLennan GS, Avenell A, Bolland M, Grey A, Witham M. Cardiovascular disease and vitamin D supplementation: trial analysis, systematic review, and meta-analysis. Am J Clin Nutr. 2014;100(3):746-55.
23. Elamin MB, Abu Elnour NO, Elamin KB, Fatourechi MM, Alkatib AA, Almandoz JP, et al. Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2011;96(7):1931-42.
24. Neves KR, Graciolli FG, dos Reis LM, Graciolli RG, Neves CL, Magalhaes AO, et al. Vascular calcification: contribution of parathyroid hormone in renal failure. Kidney Int. 2007;71(12):1262-70.
25. Kun MX, Zhen LZ, Jun QG, Miao LH, Fei RG. Association between serum 25-hydroxyvitamin D3 concentration, parathyroid hormone, and arterial stiffness in patients with type 2 diabetes. Chin J Endocrinol Metab. 2013;29:836-9.
26. Pirro M, Manfredelli MR, Helou RS, Scarponi AM, Schillaci G, Bagaglia F, et al. Association of parathyroid hormone and 25-OH-vitamin D levels with arterial stiffness in postmenopausal women with vitamin D insufficiency. J Atheroscler Thromb. 2012;19(10):924-31.
27. Blondon M, Sachs M, Hoofnagle AN, Ix JH, Michos ED, Korcarz C, et al. 25-hydroxyvitamin D and parathyroid hormone are not associated with carotid intima-media thickness or plaque in the Multi-Ethnic Study of Atherosclerosis. Arterioscler Thromb Vasc Biol. 2013;33(11):2639-45.
28. Deleskog A, Piksasova O, Silveira A, Gertow K, Baldassarre D, Veglia F, et al. Serum 25-hydroxyvitamin D concentration in subclinical carotid atherosclerosis. Arterioscler Thromb Vasc Biol. 2013;33(11):2633-8.
29. van Dijk SC, Sohl E, Oudshoorn C, Enneman AW, Ham AC, Swart KM, et al. Non-linear associations between serum 25-OH vitamin D and indices of arterial stiffness and arteriosclerosis in an older population. Age Ageing. 2015;44(1):136-42.
30. Shroff R, Egerton M, Bridel M, Shah V, Donald AE, Cole TJ, et al. A Bimodal Association of Vitamin D Levels and Vascular Disease in Children on Dialysis. Clin J Am Soc Nephrol. 2008;19(6):1239-46.
31. Melamed ML, Michos ED, Post W, Astor B. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med. 2008;168(15):1629-37.
32. Querfeld U. Vitamin D, and inflammation. Pediatr Nephrol. 2013;28(4):605-10.
33. Mizobuchi M, Ogata H, Koiwa F, Kinugasa E, Akizawa T. Vitamin D and vascular calcification in chronic kidney disease. Bone. 2009;45 Suppl 1:S26-9.
34. Hsu JJ, Tintut Y, Demer LL. Vitamin D and osteogenic differentiation in the artery wall. Clin J Am Soc Nephrol. 2008;3(5):1542-7.
35. Zittermann A, Koerfer R. Protective and toxic effects of vitamin D on vascular calcification: Clinical implications. Mol Asp Med. 2008;29(6):423-32.
36. Zittermann A, Schleithoff SS, Koerfer R. Vitamin D and vascular calcification. Curr Opin Lipidol. 2007;18(1):41-6.
37. Kuro-o M. Overview of the FGF23-Klotho axis. Pediatr Nephrol. 2010;25(4):583-90.
38. Pavik I, Jaeger P, Ebner L, Wagner CA, Petzold K, Spichtig D, et al. Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study. Nephrol Dial Transplant. 2013;28(2):352-9.
39. Carbone F, Mach F, Vuilleumier N, Montecucco F. Potential pathophysiological role for the vitamin D deficiency in essential hypertension. World J Cardiol. 2014;6(5):260-76.
40. Perkovic V, Hewitson TD, Kelynack KJ, Martic M, Tait MG, Becker GJ. Parathyroid hormone has a prosclerotic effect on vascular smooth muscle cells. Kidney Blood Pressure Res. 2003;26(1):27-33.
41. Olauson H, Vervloet MG, Cozzolino M, Massy ZA, Urena Torres P, Larsson TE. New insights into the FGF23-Klotho axis. Semin Nephrol. 2014;34(6):586-97.
42. Jimbo R, Kawakami-Mori F, Mu S, Hirohama D, Majtan B, Shimizu Y, et al. Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of Klotho deficiency. Kidney Int. 2014;85(5):1103-11.
43. Martín-Núñez E, Donate-Correa J, Muros-de-Fuentes M, Mora-Fernández C, Navarro-González JF. Implications of Klotho in vascular health and disease. World J Cardiol. 2014;6(12):1262-9.
44. Chang JR, Guo J, Wang Y, Hou YL, Lu WW, Zhang JS, et al. Intermedin1-53 attenuates vascular calcification in rats with chronic kidney disease by upregulation of alpha-Klotho. Kidney Int. 2016;89(3):586-600.
45. Covic A, Kanbay M, Voroneanu L, Turgut F, Serban DN, Serban IL, et al. Vascular calcification in chronic kidney disease. Clin Sci (London, England: 1979). 2010;119(3):111-21.